Concepedia

Second-line Antituberculosis Therapy

Second-Line Antituberculosis Therapy is a category of antimicrobial treatment regimen, within the broader field of tuberculosis pharmacotherapy, specifically reserved for managing drug-resistant tuberculosis or cases intolerant to first-line agents, distinguished by its use of less effective, more toxic, and often more expensive agents such as injectable aminoglycosides, fluoroquinolones, and newer agents like bedaquiline and delamanid.

215

Publications

12.6K

Citations

1.5K

Authors

534

Institutions

Publications per year

2017–2026

62

Parents

Publications

215

The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis

Andreas H. Diacon, Alexander S. Pym, Martin P. Grobusch et al. · New England Journal of Medicine · 2009 · 839 citations · Full text

, , +14

Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis

Francesca Conradie, Tatevik R. Bagdasaryan, Borisov Se et al. · New England Journal of Medicine · 2022 · 565 citations · Full text

, , +13

Emergence of Mycobacterium tuberculosis with Extensive Resistance to Second-Line Drugs--Worldwide, 2000-2004

PsycEXTRA Dataset · 2006 · 515 citations

, , +16

Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis

Alexander S. Pym, Andreas H. Diacon, Shenjie Tang et al. · European Respiratory Journal · 2015 · 341 citations · Full text

, , +14

Frequency and Factors Associated With Adverse Events Among Multi-Drug Resistant Tuberculosis Patients in Pakistan: A Retrospective Study

Muhammad Atif, Waqar Ahmed, Muhammad Nouman Iqbal et al. · Frontiers in Medicine · 2022 · 319 citations · Full text

, , +16

1–5 of 215

Authors

1.5K

  1. CD
    Carole D. Mitnick

    Harvard University, United States

    5 publications · 385 citations

    5

    h-index

  2. CE
    Clifton E. Barry

    National Institute of Allergy and Infectious Diseases, United States

    4 publications · 220 citations

    4

    h-index

  3. MR
    Mario Raviǵlione

    World Health Organization, Switzerland

    4 publications · 446 citations

    4

    h-index

  4. JP
    J. Peter Cegielski

    Centers for Disease Control and Prevention, United States

    4 publications · 249 citations

    4

    h-index

  5. JH
    Jae Ho Lee

    Seoul National University Bundang Hospital, South Korea

    4 publications · 114 citations

    4

    h-index

1–5 of 1.5K

Institutions

534

  1. University of Cape Town

    Rondebosch, South Africa

    9 h-index

    27 publications

    1.2K citations

  2. Johns Hopkins University

    Baltimore, United States

    8 h-index

    25 publications

    1.6K citations

  3. Stellenbosch University

    Stellenbosch, South Africa

    8 h-index

    30 publications

    3.6K citations

  4. Harvard University

    Cambridge, United States

    8 h-index

    27 publications

    2K citations

  5. University College London

    London, United Kingdom

    7 h-index

    48 publications

    13.6K citations

  6. Seoul National University Bundang Hospital

    Seongnam-si, South Korea

    6 h-index

    16 publications

    374 citations

  7. National Institutes of Health

    Bethesda, United States

    6 h-index

    17 publications

    931 citations

  8. International Union Against Tuberculosis and Lung Disease

    Paris, France

    6 h-index

    10 publications

    1.2K citations

1–8 of 534

Venues

  1. Antimicrobial Agents and Chemotherapy

    AAC · 17 publications · 979 citations

    17

    h-index

  2. PubMed

    Repository · 25 publications · 978 citations

    17

    h-index

  3. Clinical Infectious Diseases

    CID · 10 publications · 847 citations

    10

    h-index

  4. 10

    h-index

  5. Journal of Clinical Microbiology

    JCM · 10 publications · 646 citations

    10

    h-index

1–5